GB1184110A - Compositions for Treating Mental Disorders - Google Patents
Compositions for Treating Mental DisordersInfo
- Publication number
- GB1184110A GB1184110A GB51892/67A GB5189267A GB1184110A GB 1184110 A GB1184110 A GB 1184110A GB 51892/67 A GB51892/67 A GB 51892/67A GB 5189267 A GB5189267 A GB 5189267A GB 1184110 A GB1184110 A GB 1184110A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- pharmaceutically acceptable
- desipramine
- imipramine
- nov
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000020016 psychiatric disease Diseases 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- HCYAFALTSJYZDH-UHFFFAOYSA-N Desimpramine Chemical compound C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 HCYAFALTSJYZDH-UHFFFAOYSA-N 0.000 abstract 2
- 229960003914 desipramine Drugs 0.000 abstract 2
- 229960004801 imipramine Drugs 0.000 abstract 2
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 abstract 2
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 1
- KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000002906 tartaric acid Nutrition 0.000 abstract 1
- 229960002784 thioridazine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Abstract
1,184,110. Thioridazone; imipramine; desipramine. J. R. GEIGY A.G. 15 Nov., 1967 [16 Nov., 1966; 2 Oct., 1967], No. 51892/67. Heading A5B. A pharmaceutical composition for the treatment of psychotic illnesses, depression, psychosomatic disturbances and pain comprises (a) thioridazine or a pharmaceutically acceptable salt thereof and (b) imipramine or desipramine or pharmaceutically acceptable salts thereof. The compositions may be administered orally in dosage unit forms including (c) a pharmaceutically-acceptable carrier, e.g. tablets, presscoated tablets and capsules. The compositions may contain 0.1 to 10 parts by weight of (b) per part by weight of (a). Pharmaceutically acceptable addition salts may be formed with pamoic, hydrochloric, hydrobromic, sulphuric, phosphoric, methane-sulphonic, acetic, lactic, succinic, malic, aconitic, phthalic and tartaric acids.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59467366A | 1966-11-16 | 1966-11-16 | |
| US67196467A | 1967-10-02 | 1967-10-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1184110A true GB1184110A (en) | 1970-03-11 |
Family
ID=27082048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB51892/67A Expired GB1184110A (en) | 1966-11-16 | 1967-11-15 | Compositions for Treating Mental Disorders |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE706610A (en) |
| DE (1) | DE1617508C3 (en) |
| ES (1) | ES347203A1 (en) |
| FR (1) | FR7065M (en) |
| GB (1) | GB1184110A (en) |
| IL (1) | IL28951A (en) |
| NL (1) | NL6715531A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078216A2 (en) * | 2003-03-06 | 2004-09-16 | Rina Netzwerk Rna-Technologien Gmbh | Use of a tricyclic antidepressant drug for promoting endocytosis |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443428A (en) * | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
-
1967
- 1967-11-15 NL NL6715531A patent/NL6715531A/xx unknown
- 1967-11-15 DE DE19671617508 patent/DE1617508C3/en not_active Expired
- 1967-11-15 FR FR128262A patent/FR7065M/fr not_active Expired
- 1967-11-15 ES ES347203A patent/ES347203A1/en not_active Expired
- 1967-11-15 GB GB51892/67A patent/GB1184110A/en not_active Expired
- 1967-11-15 IL IL2895167A patent/IL28951A/en unknown
- 1967-11-16 BE BE706610D patent/BE706610A/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078216A2 (en) * | 2003-03-06 | 2004-09-16 | Rina Netzwerk Rna-Technologien Gmbh | Use of a tricyclic antidepressant drug for promoting endocytosis |
| WO2004078216A3 (en) * | 2003-03-06 | 2005-01-06 | Rina Netzwerk Rna Technologien | Use of a tricyclic antidepressant drug for promoting endocytosis |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1617508A1 (en) | 1972-03-23 |
| DE1617508B2 (en) | 1973-02-01 |
| NL6715531A (en) | 1968-05-17 |
| ES347203A1 (en) | 1969-05-16 |
| IL28951A (en) | 1971-10-20 |
| FR7065M (en) | 1969-06-23 |
| BE706610A (en) | 1968-05-16 |
| DE1617508C3 (en) | 1974-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Donlon | The therapeutic use of diazepam for akathisia. | |
| GB1192812A (en) | 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts | |
| US4021555A (en) | Pharmaceutical preparation and method for treatment of parkinsonism | |
| US3557292A (en) | Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine | |
| GB1184110A (en) | Compositions for Treating Mental Disorders | |
| GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
| GB1210968A (en) | Improvements in or relating to the treatment of gastric ailments | |
| GB1187348A (en) | New Amidoximes and process for the preparation thereof | |
| Korol et al. | Conditioned physiological adaptation to anticholinergic drugs | |
| ES354055A1 (en) | Anilides of quinuclidine-2- and quinuclidine-3-carboxylic acid | |
| GB1327469A (en) | Pharmaceutical compositions for inhibiting indoleamine n-methyl transferase | |
| GB1143061A (en) | Improvements in or relating to compositions affecting learning and retention | |
| GB1300486A (en) | Compositions for the treatment of respiratory ailments in man | |
| GB1337068A (en) | Muscle-relaxant compositions | |
| GB1254893A (en) | Therapeutic composition | |
| GB1352392A (en) | Phenylisopropylamine derivatives | |
| GB1050396A (en) | ||
| GB1254057A (en) | Improvements in or relating to therapeutical composition containing vincamine | |
| GB1187873A (en) | Pharmaceutical Compositions Comprising a Cardiac Glycoside. | |
| Tallarida et al. | Clinoril®(Merck Sharp & Dohme) Sulindac | |
| Meshel et al. | Double-blind study of tybamate in psychotic patients. | |
| GB1207745A (en) | A tranquillizer-containing composition | |
| GB1176049A (en) | N-Substituted Noratropinium Salts | |
| GB1167688A (en) | Dealkylation of Cyclic N-alkyl Derivatives | |
| GB1242315A (en) | Improvements in pharmaceutical compositions for treating nervous disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLE | Entries relating assignments, transmissions, licences in the register of patents | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |